Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Canada / NCT06924671
Recruiting Observational

GLA:D Back Canada - a Program for Chronic and Persistent Low Back Pain

NCT06924671 · tracked via the Priya Life Science Canada tracker
Sponsor
University of Alberta
Phase
Observational
Started
2021-06-18
Last updated
2026-04-13

Condition(s) studied

Low Back Pain

Investigational drug(s) / intervention(s)

GLA:D Back

GLA:D Back: GLA:D Back is a 10-week program based on first-line recommendations of patient education and structured exercise taught in a group format.

Study summary

GLA:D Back is a program developed in Denmark to help people with persistent low back pain. This study will assist in contextualizing Danish content into an English version of the program.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients must have persistent low back pain of at least 1 month's duration. Exclusion Criteria: * Participating currently in a supervised exercise or rehabilitation program or enrolled in another interventional clinical trial. * Patients with nerve root involvement, suspected serious pathology, unstable trauma to the spine, aspects of pregnancy or other conditions that would prevent participation or disallow trial completion within the prescribed time period. * Persons with conditions that require a specialist consult are suspected of needing a specialist consult, or have conditions that would be aggravated or worsened if treated by the interventions in this study.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Alberta Edmonton Alberta Recruiting

More University of Alberta trials in Canada

Clinical Evaluation of Reverse Versus Anatomic Shoulder Arthroplasty Techniques in the Treatment of Osteoarthritis Active, not recruiting
The Alberta Neonatal Abstinence Syndrome Mother-Baby Care ImprovEmeNT Program Recruiting
Metabolic and Inflammatory Outcomes of the Ketogenic Diet Comparing Saturated and Unsaturated Fat Sources Recruiting
Fish Oil, Metformin and Heart Health in PCOS Recruiting
Non-invasive Therapy to Drive Nerve Regeneration Enrolling by invitation

Other trials for the same condition

Alberta Back Care Pathway (ABCp) Recruiting
Back to Living Well: Implementation of a Community-based Program for Low Back Pain Active, not recruiting
Which Model of Care is the Most Cost-effective in the Treatment of Musculoskeletal Disorders? Recruiting
Quebec Low Back Pain Study: Core Dataset Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06924671 on ClinicalTrials.gov ↗ ← All trials in Canada